John E Levine, MD

img_John E Levine
PROFESSOR | Medicine, Hematology and Medical Oncology
PROFESSOR | Pediatrics
Are you a patient?
Specialties
Pediatrics, Pediatric Hematology-Oncology
Research Topics
Translational Research, Transplantation
Immunosuppression, T Cells, Transplantation
My research focuses on clinical bone marrow transplantation. My primary research focus concentrates on clinical and translational studies for the diagnosis, prevention, and treatment of acute graft-versus-host disease (GVHD). In collaboration with the laboratory of James Ferrara, we developed and validated a GVHD plasma biomarker based scoring system that assigns patients to GVHD risk strata and can be used to determine treatment intensity.

MD, Eastern Virginia Medical School

Residency, Pediatrics, Childrens Hospital-Los Angeles

Residency, Pediatrics, Children's Hospital of Los Angeles

Fellowship, Pediatric Hematology-Oncology, Memorial Sloan-Kettering Cancer Center

Fellowship, Pediatric Hematology-Oncology, Memorial Sloan-Kettering Cancer Center

Fellowship, Pediatric Blood & Marrow Transplant, Memorial Sloan-Kettering Cancer Center

2013

Chair, Pediatric Scientific Interest Group, ASBMT Annual Meeting

2012

Chair, Scientific Program, ASBMT Annual Meeting

2007

Best Doctors in America

2005

Ford Motor Company Leadership in Health Award

Publications

Selected Publications

Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL. Stephan A. Grupp, Shannon L. Maude, Susana Rives, Hidefumi Hiramatsu, Andre Baruchel, Peter Bader, Henrique Bittencourt, Jochen Buechner, Theodore W. Laetsch, Barbara De Moerloose, Muna Qayed, Heather E. Stefanski, Kara L. Davis, Timothy A. Driscoll, Eneida Nemecek, Christina Peters, Gregory Yanik, Adriana Balduzzi, Nicolas Boissel, Seong Lin Khaw, Joerg Krueger, John E. Levine, Gary Douglas Myers, Ranjan Tiwari, Darragh O'Donovan, Rakesh Awasthi, Roberto Ramos, Jennifer Willert, Michael A. Pulsipher. Journal of Clinical Oncology

Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant. Susan Dewolf, Steven J. Siegel, Joseph Schmalz, Wael Saber, Alexandre Albanese, Jiayi Dong, Michael J. Martens, Brent Logan, Lorenzo Iovino, Kayleigh Ingersoll-Ohmdahl, Nicholas Winn, Edward Chen, James Kaminski, Donna Neuberg, Kyle Hebert, Paula Keskula, Jillian Zavistaski, Lea Steinberg, Isabella Schichter, Zoe Katsamakis, Lorenzo Cagnin, Vanessa Hernandez, Makya Warren, Kristy Applegate, Merav Bar, Saurabh Chhabra, Sung Won Choi, William Clark, Suman Das, Robert Jenq, Richard J. Jones, John E. Levine, Hemant Murthy, Armin Rashidi, Marcie Riches, Karamjeet Sandhu, Anthony D. Sung, Karilyn Larkin, Monzr M. Al Malki, Mahasweta Gooptu, Hany Elmariah, Amin Alousi, Lyndsey Runaas, Brian Shaffer, Andrew Rezvani, Najla El Jurdi, Alison W. Loren, Danielle Scheffey, Catherine Sanders, Mehdi Hamadani, Jarrod A. Dudakov, Stephanie Bien, Harlan Robins, Mary Horowitz, Javier Bolaños-Meade, Shernan Holtan, Ami S. Bhatt, Miguel Angel Perales, Leslie S. Kean. Science Translational Medicine

Clinical Management of Acute Graft-Versus-Host Disease: An Evidence-Based Review from the ASTCT Committee on Practice Guidelines. Zachariah DeFilipp, Amin Alousi, John E. Levine, Shernan G. Holtan, Sameem Abedin, Mahasweta Gooptu, Andrew C. Harris, John M. Magenau, Iskra Pusic, Mark A. Schroeder, Yi Bin Chen, Margaret L. MacMillan, Monzr M. Al Malki, Mehdi Hamadani, Paul A. Carpenter, Betty K. Hamilton. Transplantation and Cellular Therapy

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Levine during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Glaxosmithkline
  • Mesoblast Inc
  • Equillium, Inc. HQ
  • Aimmune Therapeutics, Inc.
  • Sanofi Aventis
  • X4 Pharmaceuticals
  • Genetix

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.